Where I see patients (1)
My reviews
Selected research
-
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Blood advances
-
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Clinical lymphoma, myeloma & leukemia
-
It's All in the Timing.
The New England journal of medicine
Clinical trials
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
The feasibility of completing molecular, genetic, immunophenotypic, and biochemical testing for assignment of therapy will be assessed based on the proportion of patients for whom testing is completed within 7 days of the registra...
Recruiting
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Tra...
The arm with the largest mean change in Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) from baseline to day 90. The Wilcoxon rank-sum test will be used to compare change in FACT-BMT between arms, and thi...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9